BDSX vs ECL
Biodesix Inc (BDSX) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Biodesix Inc (BDSX) is a diagnostics & research company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported BDSX revenue for 2024-12-31 was $71.3M. Net income was -$42.9M. Revenue was up 45.3% from 2023-12-31 to 2024-12-31. BDSX currently screens at market cap $157.6M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
BDSX currently screens at market cap $157.6M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the BDSX and ECL stock pages for the full models.
Not investment advice.